{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:44:00Z","timestamp":1791895440692,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/35\/O\/NZ7\/00227"],"award-info":[{"award-number":["2019\/35\/O\/NZ7\/00227"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["319195"],"award-info":[{"award-number":["319195"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["293392"],"award-info":[{"award-number":["293392"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["324177"],"award-info":[{"award-number":["324177"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007083","name":"Orionin Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014434","name":"Narodowa Agencja Wymiany Akademickiej","doi-asserted-by":"publisher","award":["PPN\/STA\/2021\/1\/00060\/DEC\/1"],"award-info":[{"award-number":["PPN\/STA\/2021\/1\/00060\/DEC\/1"]}],"id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014434","name":"Narodowa Agencja Wymiany Akademickiej","doi-asserted-by":"publisher","award":["2019\/35\/D\/NZ7\/03200"],"award-info":[{"award-number":["2019\/35\/D\/NZ7\/03200"]}],"id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030905","name":"Suomen Parkinson-s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"Helsingin Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejps.2025.107048","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:10:45Z","timestamp":1740125445000},"page":"107048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["GDNF reduces fibril-induced early-stage alpha-synuclein pathology after delivery of 20S proteasome inhibitor lactacystin"],"prefix":"10.1016","volume":"208","author":[{"given":"Safak","family":"Er","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilmari","family":"Parkkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Trepczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Seelbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Samuela","family":"Pasculli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Chmielarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrii","family":"Domanskyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2026-1609","authenticated-orcid":false,"given":"Mikko","family":"Airavaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107048_bib0039","doi-asserted-by":"crossref","DOI":"10.1002\/cpns.88","article-title":"Back and to the future: from neurotoxin-induced to Human Parkinson's disease models","volume":"91","author":"Airavaara","year":"2020","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.ejps.2025.107048_bib0069","article-title":"Downregulation of tyrosine hydroxylase phenotype after AAV injection above substantia nigra: caution in experimental models of Parkinson's disease","author":"Albert","year":"2018","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejps.2025.107048_bib0048","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1016\/j.ymthe.2021.04.035","article-title":"Cerebral dopamine neurotrophic factor reduces \u03b1-synuclein aggregation and propagation and alleviates behavioral alterations in vivo","volume":"29","author":"Albert","year":"2021","journal-title":"Mol. Therapy"},{"key":"10.1016\/j.ejps.2025.107048_bib0006","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s40478-022-01468-8","article-title":"Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across lewy body disorders","volume":"10","author":"Altay","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ejps.2025.107048_bib0052","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2016.01.002","article-title":"Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system","volume":"88","author":"Barroso-Chinea","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejps.2025.107048_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2015.00068","article-title":"Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated \u03b1-synuclein","volume":"9","author":"Bentea","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ejps.2025.107048_bib0067","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"The Lancet"},{"key":"10.1016\/j.ejps.2025.107048_bib0073","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/gb-2006-7-10-r100","article-title":"CellProfiler: image analysis software for identifying and quantifying cell phenotypes","volume":"7","author":"Carpenter","year":"2006","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejps.2025.107048_bib0010","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/mds.28258","article-title":"GDNF\/RET signaling pathway activation eliminates lewy body pathology in midbrain dopamine neurons","volume":"35","author":"Chmielarz","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejps.2025.107048_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105298","article-title":"GDNF signaling in subjects with minimal motor deficits and Parkinson's disease","volume":"153","author":"Chu","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejps.2025.107048_bib0019","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00441-020-03268-9","article-title":"GDNF\/RET signaling in dopamine neurons in vivo","volume":"382","author":"Conway","year":"2020","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejps.2025.107048_bib0022","first-page":"1292","article-title":"Impaired degradation of mutant \u03b1-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science (1979)"},{"key":"10.1016\/j.ejps.2025.107048_bib0064","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1093\/brain\/awr149","article-title":"GDNF fails to exert neuroprotection in a rat -synuclein model of Parkinson's disease","volume":"134","author":"Decressac","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ejps.2025.107048_bib0065","first-page":"4","article-title":"\u03b1-synuclein\u2013Induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons","author":"Decressac","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejps.2025.107048_bib0031","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3181\/0712-RM-329","article-title":"Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration In vivo","volume":"233","author":"Du","year":"2008","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.ejps.2025.107048_bib0060","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4161\/auto.5.5.8377","article-title":"An insight into the mechanistic role of p53-mediated autophagy induction in response to proteasomal inhibition-induced neurotoxicity","volume":"5","author":"Du","year":"2009","journal-title":"Autophagy."},{"key":"10.1016\/j.ejps.2025.107048_bib0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000334527","article-title":"Adeno-associated virus type 2 vector-mediated glial cell line-derived neurotrophic factor gene transfer induces neuroprotection and neuroregeneration in a ubiquitin-proteasome system impairment animal model of Parkinson's disease","volume":"11","author":"Du","year":"2013","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.ejps.2025.107048_bib0040","first-page":"61118","article-title":"Studying pre-formed fibril induced \u03b1-synuclein accumulation in primary embryonic mouse midbrain dopamine neurons","author":"Er","year":"2020","journal-title":"JoVE"},{"key":"10.1016\/j.ejps.2025.107048_bib0036","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1523\/JNEUROSCI.23-26-08955.2003","article-title":"Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition","volume":"23","author":"Fornai","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2025.107048_bib0056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149776","article-title":"Comparative analysis of the effects of neurotrophic factors CDNF and GDNF in a nonhuman primate model of Parkinson's Disease","volume":"11","author":"Garea-Rodr\u00edguez","year":"2016","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejps.2025.107048_bib0050","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1523\/JNEUROSCI.1122-04.2004","article-title":"Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system","volume":"24","author":"Georgievska","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2025.107048_bib0057","article-title":"Biological activity In vitro, absorption, BBB penetration, and tolerability of nanoformulation of BT44:RET agonist with disease-modifying potential for the treatment of neurodegeneration","author":"Haider","year":"2022","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejps.2025.107048_bib0049","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0022-3565(24)36878-8","article-title":"Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats","volume":"282","author":"Hebert","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107048_bib0015","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/mds.27724","article-title":"Trial of magnetic resonance\u2013guided putaminal gene therapy for advanced Parkinson's disease","volume":"34","author":"Heiss","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejps.2025.107048_bib0061","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41593-019-0457-5","article-title":"Spread of \u03b1-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis","volume":"22","author":"Henderson","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejps.2025.107048_bib0043","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1021\/acschemneuro.1c00215","article-title":"Domain-independent inhibition of CBP\/p300 attenuates \u03b1-synuclein aggregation","volume":"12","author":"Hlushchuk","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejps.2025.107048_bib0012","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0304-3940(94)90218-6","article-title":"Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo","volume":"182","author":"Hoffer","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejps.2025.107048_bib0042","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1021\/acs.jnatprod.1c01172","article-title":"\u03b1-synuclein aggregation inhibitory prunolides and a dibrominated \u03b2-carboline sulfamate from the Ascidian Synoicum prunum","volume":"85","author":"Holland","year":"2022","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejps.2025.107048_bib0001","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00005072-199702000-00002","article-title":"Immunocytochemical Co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly","volume":"56","author":"Ii","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejps.2025.107048_bib0074","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1073\/pnas.0808843106","article-title":"Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learning","volume":"106","author":"Jones","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejps.2025.107048_bib0023","doi-asserted-by":"crossref","unstructured":"Konovalova, J., Er, S., Barut, J., Rafa-Zab\u0142ocka, K., Luk, K. C., Figiel, M., Airavaara, M., Domanskyi, A., & Chmielarz, P. (2022). PKB\/AKT attenuates lewy Body-like pathology in primary neurons via Cathepsins B and D (Neuroscience) doi:10.1101\/2022.09.23.508066.","DOI":"10.1101\/2022.09.23.508066"},{"key":"10.1016\/j.ejps.2025.107048_bib0054","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q","article-title":"Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease","volume":"46","author":"Kordower","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejps.2025.107048_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005710","article-title":"GDNF overexpression from the native locus reveals its role in the nigrostriatal dopaminergic system function","volume":"11","author":"Kumar","year":"2015","journal-title":"PLoS. Genet."},{"key":"10.1016\/j.ejps.2025.107048_bib0059","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41531-022-00388-7","article-title":"Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity","volume":"8","author":"Lashuel","year":"2022","journal-title":"NPJ. Parkinsons. Dis."},{"key":"10.1016\/j.ejps.2025.107048_bib0035","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/gerona\/62.9.943","article-title":"Glial cell-derived neurotrophic factor protects against proteasome inhibition-induced dopamine neuron degeneration by suppression of endoplasmic reticulum stress and caspase-3 activation","volume":"62","author":"Li","year":"2007","journal-title":"J. Gerontol. Ser. A: Biol. Sci. Med. Sci."},{"key":"10.1016\/j.ejps.2025.107048_bib0011","first-page":"1130","article-title":"GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science (1979)"},{"key":"10.1016\/j.ejps.2025.107048_bib0034","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuint.2011.03.013","article-title":"Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats","volume":"58","author":"Lorenc-Koci","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejps.2025.107048_bib0037","first-page":"949","article-title":"Pathological \u03b1-synuclein transmission initiates parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science (1979)"},{"key":"10.1016\/j.ejps.2025.107048_bib0009","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1073\/pnas.1913904117","article-title":"The process of lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration","volume":"117","author":"Mahul-Mellier","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2025.107048_bib0053","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/mt.2009.45","article-title":"Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity","volume":"17","author":"Manfredsson","year":"2009","journal-title":"Mol. Therapy"},{"key":"10.1016\/j.ejps.2025.107048_bib0063","first-page":"1","article-title":"Parkinson's Disease drug therapies in the clinical trial pipeline: 2023 update","author":"McFarthing","year":"2023","journal-title":"JPD"},{"key":"10.1016\/j.ejps.2025.107048_bib0002","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson\u2019s disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejps.2025.107048_bib0003","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1046\/j.1460-9568.2002.02301.x","article-title":"Aggresome-related biogenesis of lewy bodies: relationship between aggresomes and lewy bodies","volume":"16","author":"McNaught","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejps.2025.107048_bib0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1471-4159.2002.00821.x","article-title":"Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures: inhibition of proteolysis in dopaminergic neurons","volume":"81","author":"McNaught","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2025.107048_bib0071","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1523\/JNEUROSCI.5647-06.2007","article-title":"Constitutive ret activity in knock-In multiple endocrine neoplasia type B mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases the number of TH-positive cells in the substantia Nigra","volume":"27","author":"Mijatovic","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2025.107048_bib0058","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00401-021-02329-9","article-title":"The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy","volume":"142","author":"Moors","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejps.2025.107048_bib0032","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000202972","article-title":"Nigral degeneration with inclusion body formation and behavioral changes in rats after proteasomal inhibition","volume":"87","author":"Niu","year":"2009","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.ejps.2025.107048_bib0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.60.1.69","article-title":"Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD","volume":"60","author":"Nutt","year":"2003","journal-title":"Neurology."},{"key":"10.1016\/j.ejps.2025.107048_bib0028","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0097-22.2023","article-title":"Increased physiological GDNF levels have No effect on dopamine neuron protection and restoration in a proteasome inhibition mouse model of Parkinson's disease","volume":"10","author":"Olfat","year":"2023","journal-title":"eNeuro"},{"key":"10.1016\/j.ejps.2025.107048_bib0070","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.ejps.2025.107048_bib0014","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fneur.2018.00457","article-title":"Pre-\u03b1-pro-GDNF and Pre-\u03b2-pro-GDNF isoforms are neuroprotective in the 6-hydroxydopamine rat model of Parkinson's","volume":"9","author":"Penttinen","year":"2018","journal-title":"Disease. Front. Neurol."},{"key":"10.1016\/j.ejps.2025.107048_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2022.100472","article-title":"\u03b1-synuclein aggregation inhibitory activity of the bromotyrosine derivatives aerothionin and aerophobin-2 from the subtropical marine sponge Aplysinella sp","volume":"4","author":"Prebble","year":"2022","journal-title":"Results. Chem."},{"key":"10.1016\/j.ejps.2025.107048_bib0068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneumeth.2017.03.020","article-title":"Near-infrared fluorescent protein iRFP713 as a reporter protein for optogenetic vectors, a transgenic Cre-reporter rat, and other neuronal studies","volume":"284","author":"Richie","year":"2017","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejps.2025.107048_bib0020","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.biocel.2004.05.008","article-title":"Involvement of macroautophagy in the dissolution of neuronal inclusions","volume":"36","author":"Rideout","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejps.2025.107048_bib0046","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1471-4159.2005.03124.x","article-title":"Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions, but do not up-regulate iHSP70, following proteasomal inhibition: inclusion formation in dopamine neurons","volume":"93","author":"Rideout","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2025.107048_bib0018","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1016\/j.ymthe.2022.08.003","article-title":"Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease","volume":"30","author":"Rocco","year":"2022","journal-title":"Mol. Therapy"},{"key":"10.1016\/j.ejps.2025.107048_bib0051","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.expneurol.2009.05.013","article-title":"Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system","volume":"219","author":"Salvatore","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejps.2025.107048_bib0029","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s00221-017-4962-z","article-title":"Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse","volume":"235","author":"Savolainen","year":"2017","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.ejps.2025.107048_bib0072","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejps.2025.107048_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108822","article-title":"New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin","volume":"202","author":"Senkevich","year":"2022","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.ejps.2025.107048_bib0005","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejps.2025.107048_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137510","article-title":"Feasibility of combining alpha-synuclein aggregation and 6-OHDA in embryonic midbrain culture for modeling dopamine neuron degeneration","volume":"816","author":"Singh","year":"2023","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejps.2025.107048_bib0062","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/ejn.16196","article-title":"Combining fibril-induced alpha-synuclein aggregation and 6-hydroxydopamine in a mouse model of Parkinson's disease and the effect of cerebral dopamine neurotrophic factor on the induced neurodegeneration","volume":"59","author":"Singh","year":"2024","journal-title":"Eur J of Neuroscience"},{"key":"10.1016\/j.ejps.2025.107048_bib0007","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/cells11050906","article-title":"Pathological relevance of post-translationally modified alpha-synuclein (pSer87, pSer129, nTyr39) in idiopathic Parkinson's disease and multiple system atrophy","volume":"11","author":"Sonustun","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2025.107048_bib0075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","article-title":"CellProfiler 4: improvements in speed, utility and usability","volume":"22","author":"Stirling","year":"2021","journal-title":"BMC. Bioinformatics."},{"key":"10.1016\/j.ejps.2025.107048_bib0025","article-title":"An abundance of free regulatory (19 S) proteasome particles regulates neuronal synapses","volume":"380","author":"Sun","year":"2023","journal-title":"Science (1979)"},{"key":"10.1016\/j.ejps.2025.107048_bib0021","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0014-5793(01)03115-5","article-title":"\u03b1-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome","volume":"509","author":"Tofaris","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejps.2025.107048_bib0008","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous \u03b1-synuclein fibrils induce lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.ejps.2025.107048_bib0038","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/nprot.2014.143","article-title":"Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to lewy body and lewy neurite\u2013like aggregates","volume":"9","author":"Volpicelli-Daley","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejps.2025.107048_bib0026","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12149-017-1174-3","article-title":"[18F]FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease","volume":"31","author":"Weng","year":"2017","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.ejps.2025.107048_bib0016","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/brain\/awz023","article-title":"Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease","volume":"142","author":"Whone","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ejps.2025.107048_bib0017","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/JPD-191576","article-title":"Extended treatment with glial cell line-derived neurotrophic factor in Parkinson's disease","volume":"9","author":"Whone","year":"2019","journal-title":"JPD"},{"key":"10.1016\/j.ejps.2025.107048_bib0024","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41586-021-03185-z","article-title":"A growth-factor-activated lysosomal K+ channel regulates Parkinson's pathology","volume":"591","author":"Wie","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2025.107048_bib0013","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.1523\/JNEUROSCI.16-22-07206.1996","article-title":"Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease","volume":"16","author":"Winkler","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2025.107048_bib0047","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/acschembio.0c00634","article-title":"Fluorescent probes with unnatural amino acids to monitor proteasome activity in real-time","volume":"15","author":"Zerfas","year":"2020","journal-title":"ACS Chem. Biol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T10:17:12Z","timestamp":1742379432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725000478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":75,"alternative-id":["S0928098725000478"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107048","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GDNF reduces fibril-induced early-stage alpha-synuclein pathology after delivery of 20S proteasome inhibitor lactacystin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107048"}}